Structure Therapeutics (GPCR) Other Accumulated Expenses (2022 - 2026)

Structure Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 221.24% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 221.24% YoY), while the FY2025 annual figure was $1.4 million, down 73.55% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $8.3 million, up from $1.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $9.7 million in Q2 2025, with the low at $1.2 million in Q1 2024.
• The 5-year median for Other Accumulated Expenses is $3.0 million (2024), against an average of $3.8 million.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses sank 73.55% in 2025, then soared 221.24% in 2026.
• Structure Therapeutics' Other Accumulated Expenses stood at $1.8 million in 2022, then soared by 159.57% to $4.7 million in 2023, then gained by 15.7% to $5.5 million in 2024, then tumbled by 73.55% to $1.4 million in 2025, then jumped by 478.19% to $8.3 million in 2026.
• Business Quant data shows GPCR's Other Accumulated Expenses at $8.3 million in Q1 2026, $1.4 million in Q4 2025, and $6.6 million in Q3 2025.